83 related articles for article (PubMed ID: 16839214)
1. Myeloid leukaemia treatment and survival--the South Australian experience, 1977 to 2002.
Luke C; Nguyen AM; To B; Seshadri R; Hughes T; Bardy P; Colbeck M; Buranyi-Trevarton D; McMellon M; Roder D
Asian Pac J Cancer Prev; 2006; 7(2):227-33. PubMed ID: 16839214
[TBL] [Abstract][Full Text] [Related]
2. Treatment and survival from breast cancer: the experience of patients at South Australian teaching hospitals between 1977 and 2003.
Luke C; Gill G; Birrell S; Humeniuk V; Borg M; Karapetis C; Koczwara B; Olver I; Penniment M; Pittman K; Price T; Walsh D; Yeoh EK; Roder D
J Eval Clin Pract; 2007 Apr; 13(2):212-20. PubMed ID: 17378867
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
Gangatharan SA; Grove CS; P'ng S; O'Reilly J; Joske D; Leahy MF; Threlfall T; Wright MP
Intern Med J; 2013 Aug; 43(8):903-11. PubMed ID: 23611681
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer treatment and survival: the experience of major public hospitals in south Australia over three decades.
Roder D; Karapetis CS; Wattchow D; Moore J; Singhal N; Joshi R; Keefe D; Fusco K; Powell K; Eckert M; Price TJ
Asian Pac J Cancer Prev; 2015; 16(6):2431-40. PubMed ID: 25824777
[TBL] [Abstract][Full Text] [Related]
5. Changes in five-year survival for people with acute leukaemia in South Australia, 1980-2016.
Beckmann K; Kearney BJ; Yeung D; Hiwase D; Li M; Roder DM
Med J Aust; 2022 Apr; 216(6):296-302. PubMed ID: 35172376
[TBL] [Abstract][Full Text] [Related]
6. Trends in the treatment of acute myeloid leukaemia in the elderly.
Lang K; Earle CC; Foster T; Dixon D; Van Gool R; Menzin J
Drugs Aging; 2005; 22(11):943-55. PubMed ID: 16323971
[TBL] [Abstract][Full Text] [Related]
7. Treatment, long-term outcome and prognostic variables in 214 unselected AML patients in Sweden.
Aström M; Bodin L; Nilsson I; Tidefelt U
Br J Cancer; 2000 Apr; 82(8):1387-92. PubMed ID: 10780515
[TBL] [Abstract][Full Text] [Related]
8. Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: a single institution retrospective study.
Thomas DM; Seymour JF; Szer J; Grigg AP; Basser RL; Green MD; Fox RM
Aust N Z J Med; 1998 Apr; 28(2):190-6. PubMed ID: 9612527
[TBL] [Abstract][Full Text] [Related]
9. Treatment and survival from colorectal cancer: the experience of patients at South Australian teaching hospitals between 1980 and 2002.
Luke CG; Koczwara B; Moore JE; Olver IN; Penniment MG; Pittman K; Price TJ; Rieger NA; Roediger BW; Wattchow DA; Young GP; Roder DM
Clin Oncol (R Coll Radiol); 2005 Aug; 17(5):372-81. PubMed ID: 16097570
[TBL] [Abstract][Full Text] [Related]
10. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
[TBL] [Abstract][Full Text] [Related]
11. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Röllig C; Serve H; Hüttmann A; Noppeney R; Müller-Tidow C; Krug U; Baldus CD; Brandts CH; Kunzmann V; Einsele H; Krämer A; Schäfer-Eckart K; Neubauer A; Burchert A; Giagounidis A; Krause SW; Mackensen A; Aulitzky W; Herbst R; Hänel M; Kiani A; Frickhofen N; Kullmer J; Kaiser U; Link H; Geer T; Reichle A; Junghanß C; Repp R; Heits F; Dürk H; Hase J; Klut IM; Illmer T; Bornhäuser M; Schaich M; Parmentier S; Görner M; Thiede C; von Bonin M; Schetelig J; Kramer M; Berdel WE; Ehninger G;
Lancet Oncol; 2015 Dec; 16(16):1691-9. PubMed ID: 26549589
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study.
Behringer B; Pitako JA; Kunzmann R; Schmoor C; Behringer D; Mertelsmann R; Lübbert M
Ann Hematol; 2003 Jul; 82(7):381-9. PubMed ID: 12756497
[TBL] [Abstract][Full Text] [Related]
13. De novo acute myeloid leukaemia in patients over 55-years-old: a population-based study of incidence, treatment and outcome. Northern Region Haematology Group.
Taylor PR; Reid MM; Stark AN; Bown N; Hamilton PJ; Proctor SJ
Leukemia; 1995 Feb; 9(2):231-7. PubMed ID: 7532766
[TBL] [Abstract][Full Text] [Related]
14. Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival.
Roder D; Davy M; Selva-Nayagam S; Paramasivam S; Adams J; Keefe D; Olver I; Miller C; Buckley E; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
BMC Cancer; 2018 Aug; 18(1):858. PubMed ID: 30165835
[TBL] [Abstract][Full Text] [Related]
15. Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.
Juliusson G; Billström R; Gruber A; Hellström-Lindberg E; Höglunds M; Karlsson K; Stockelberg D; Wahlin A; Aström M; Arnesson C; Brunell-Abrahamsson U; Carstensen J; Fredriksson E; Holmberg E; Nordenskjöld K; Wiklund F;
Leukemia; 2006 Jan; 20(1):42-7. PubMed ID: 16327841
[TBL] [Abstract][Full Text] [Related]
16. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
[TBL] [Abstract][Full Text] [Related]
17. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
18. Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.
Schlenk RF; Benner A; Hartmann F; del Valle F; Weber C; Pralle H; Fischer JT; Gunzer U; Pezzutto A; Weber W; Grimminger W; Preiss J; Hensel M; Fröhling S; Döhner K; Haas R; Döhner H;
Leukemia; 2003 Aug; 17(8):1521-8. PubMed ID: 12886238
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
Koistinen P; Räty R; Itälä M; Jantunen E; Koivunen E; Nousiainen T; Pelliniemi TT; Remes K; Ruutu T; Savolainen ER; Siitonen T; Silvennoinen R; Volin L; Elonen E;
Eur J Haematol; 2007 Jun; 78(6):477-86. PubMed ID: 17391337
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of efficacy and prognosis of induction chemotherapy in 76 elderly patients with acute myeloid leukemia (non-APL)].
Yang H; Niu JH; Zhu CY; Zhang Q; Zhu HY; Yao ZL; Zhou MH; Wang QS; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):957-64. PubMed ID: 25130810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
